Evidence map›Paper›PMID 19631002›Full record

ArticleBMC nephrology2009

Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.

Stacey O'Shea, Carmel M Hawley, Stephen P McDonald, Fiona G Brown, Johan B Rosman, Kathryn J Wiggins, Kym M Bannister, David W Johnson

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC nephrology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  10. BMJ case reports · 2018
    Article
  11. Peritoneal dialysis-related peritonitis: challenges and solutions.International journal of nephrology and renovascular disease · 2018
    Review
  12. Review
  13. Article
  14. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2016
    Review
  15. Article
  16. Peritoneal Dialysis-Related Peritonitis Due toCanadian journal of kidney health and disease · 2016
    Article
  17. Article
  18. Article
  19. Peritonitis and exit site infections in First Nations patients on peritoneal dialysis.Clinical journal of the American Society of Nephrology : CJASN · 2010
    Article
  20. Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Stacey O'SheaAustralia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia. stacey_oshea@health.qld.gov.au
Carmel M Hawley
Stephen P McDonald
Fiona G Brown
Johan B Rosman
Kathryn J Wiggins
Kym M Bannister
David W Johnson
Australia and New Zealand Dialysis and Transplant Registry · AUMiddlemore Hospital · NZMonash Medical Centre · AUPrincess Alexandra Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere has not been a comprehensive, multi-centre study of streptococcal peritonitis in patients on peritoneal dialysis (PD) to date.

methodsThe predictors, treatment and clinical outcomes of streptococcal peritonitis were examined by binary logistic regression and multilevel, multivariate poisson regression in all Australian PD patients involving 66 centres between 2003 and 2006.

resultsTwo hundred and eighty-seven episodes of streptococcal peritonitis (4.6% of all peritonitis episodes) occurred in 256 individuals. Its occurrence was independently predicted by Aboriginal or Torres Strait Islander racial origin. Compared with other organisms, streptococcal peritonitis was associated with significantly lower risks of relapse (3% vs 15%), catheter removal (10% vs 23%) and permanent haemodialysis transfer (9% vs 18%), as well as a shorter duration of hospitalisation (5 vs 6 days). Overall, 249 (87%) patients were successfully treated with antibiotics without experiencing relapse, catheter removal or death. The majority of streptococcal peritonitis episodes were treated with either intraperitoneal vancomycin (most common) or first-generation cephalosporins for a median period of 13 days (interquartile range 8-18 days). Initial empiric antibiotic choice did not influence outcomes.

conclusionStreptococcal peritonitis is a not infrequent complication of PD, which is more common in indigenous patients. When treated with either first-generation cephalosporins or vancomycin for a period of 2 weeks, streptococcal peritonitis is associated with lower risks of relapse, catheter removal and permanent haemodialysis transfer than other forms of PD-associated peritonitis.

Indexed as

AgedAnti-Bacterial AgentsAustraliaCephalosporinsFemaleFollow-Up StudiesHumansLogistic ModelsMaleMiddle AgedPeritoneal DialysisPeritonitisPredictive Value of TestsPrevalenceRetrospective StudiesRisk FactorsAnti-Bacterial AgentsCephalosporinsVancomycin

Identifiers

PMID19631002
PMCPMC2721833
OpenAlexW2112594227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.